Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
作者信息
Chedid Marcio F, Rodrigo Emilio
机构信息
Liver and Pancreas Transplant and Hepatobiliary Surgery Unit, Hospital de Clinicas de Porto Alegre, Medical School of UFRGS, Porto Alegre, Brazil.
Brazilian National Academy of Medicine Rio de Janeiro, Brazil.
出版信息
Transplant Direct. 2019 Sep 23;5(10):e492. doi: 10.1097/TXD.0000000000000931. eCollection 2019 Oct.
Abstract
摘要
相似文献
1
Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?硼替佐米：肝移植后早期抗体介导性排斥反应的一种新的有前景的治疗方法？
Transplant Direct. 2019 Sep 23;5(10):e492. doi: 10.1097/TXD.0000000000000931. eCollection 2019 Oct.
2
Treatment of antibody-mediated rejection in kidney transplant recipients: a single-center experience with a bortezomib-based regimen.肾移植受者抗体介导性排斥反应的治疗：基于硼替佐米方案的单中心经验
Exp Clin Transplant. 2012 Dec;10(6):609-13. doi: 10.6002/ect.2012.0131.
3
Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.硼替佐米用于治疗儿童肾移植受者抗体介导的排斥反应：一项中西部儿科肾脏病学联合会多中心研究
Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12873. Epub 2017 Jan 16.
4
5
Antibody-Mediated Rejection in Adult Liver Transplant Recipients: A Case Series and Literature Review.成人肝移植受者抗体介导的排斥反应：病例系列及文献复习。
J Clin Pharmacol. 2022 Feb;62(2):254-271. doi: 10.1002/jcph.1963. Epub 2022 Jan 17.
6
Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.硼替佐米抑制蛋白酶体：肾移植后严重抗体介导排斥反应的有效治疗方法。
Clin Nephrol. 2012 Mar;77(3):246-53. doi: 10.5414/cn107156.
7
Treatment of acute antibody-mediated rejection using bortezomib: a case report.使用硼替佐米治疗急性抗体介导的排斥反应：一例病例报告。
Nephrology (Carlton). 2015 Jul;20 Suppl 2:86-9. doi: 10.1111/nep.12459.
8
Bortezomib for acute antibody-mediated rejection in liver transplantation.硼替佐米治疗肝移植术后急性抗体介导排斥反应。
Am J Transplant. 2012 Sep;12(9):2526-31. doi: 10.1111/j.1600-6143.2012.04126.x. Epub 2012 Jun 8.
9
The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.硼替佐米对肾移植后抗体介导排斥反应的影响。
Yonsei Med J. 2015 Nov;56(6):1638-42. doi: 10.3349/ymj.2015.56.6.1638.
10
Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody-Validity of Bortezomib and Everolimus: A Case Report.脱敏预处理后肝移植中发生的难治性急性抗体介导排斥反应：硼替佐米和依维莫司的有效性：一例报告。
Transplant Proc. 2022 Jan-Feb;54(1):147-152. doi: 10.1016/j.transproceed.2021.11.022. Epub 2021 Dec 30.
引用本文的文献
1
Successful Use of Bortezomib for Recurrent Progressive Familial Intrahepatic Cholestasis Type II After Liver Transplantation: A Pediatric Case with a 9-Year Follow-Up.硼替佐米成功用于肝移植后复发性进行性家族性肝内胆汁淤积症II型：1例随访9年的儿科病例
Pediatr Gastroenterol Hepatol Nutr. 2024 Jan;27(1):71-76. doi: 10.5223/pghn.2024.27.1.71. Epub 2024 Jan 9.
2
Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?异种移植中的抗体介导排斥反应：能否预防或逆转？
Xenotransplantation. 2023 Jul-Aug;30(4):e12816. doi: 10.1111/xen.12816. Epub 2023 Aug 7.
3
Immunotherapy for Refractory Autoimmune Encephalitis.免疫疗法治疗难治性自身免疫性脑炎。
Front Immunol. 2021 Dec 16;12:790962. doi: 10.3389/fimmu.2021.790962. eCollection 2021.
本文引用的文献
1
Bortezomib Against Refractory Antibody-Mediated Rejection After ABO-Incompatible Living-Donor Liver Transplantation: Dramatic Effect in Acute-Phase?硼替佐米治疗ABO血型不合活体供肝移植后难治性抗体介导的排斥反应：急性期疗效显著？
Transplant Direct. 2019 Sep 19;5(10):e491. doi: 10.1097/TXD.0000000000000932. eCollection 2019 Oct.
2
Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis.根据 ABO 相容性进行肝移植的结果：系统评价和荟萃分析。
World J Gastroenterol. 2017 Sep 21;23(35):6516-6533. doi: 10.3748/wjg.v23.i35.6516.
3
Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.在单一机构使用简化方案进行ABO血型不相容肝移植的结果。
Transplant Proc. 2015 Apr;47(3):723-6. doi: 10.1016/j.transproceed.2015.02.004.
4
Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib.尽管使用利妥昔单抗、脾切除术和硼替佐米进行了不成功的抗 HLA 抗体减少治疗，但一位高度致敏的肝肾联合移植患者仍实现了 4 年的移植物存活。
Transpl Int. 2013 Aug;26(8):e64-8. doi: 10.1111/tri.12120. Epub 2013 May 15.
5
Bortezomib for acute antibody-mediated rejection in liver transplantation.硼替佐米治疗肝移植术后急性抗体介导排斥反应。
Am J Transplant. 2012 Sep;12(9):2526-31. doi: 10.1111/j.1600-6143.2012.04126.x. Epub 2012 Jun 8.
6
Bortezomib is effective to treat acute humoral rejection after liver transplantation.硼替佐米对治疗肝移植术后急性体液排斥反应有效。
Transplant Proc. 2012 Mar;44(2):529-31. doi: 10.1016/j.transproceed.2012.01.051.
7
Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.硼替佐米与利妥昔单抗治疗抗体介导的肾移植排斥反应的比较。
Nephrol Dial Transplant. 2012 Mar;27(3):1246-51. doi: 10.1093/ndt/gfr465. Epub 2011 Aug 17.
8
Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation.血型相容肝移植后急性体液排斥反应的临床视角
Transplantation. 2011 Mar 15;91(5):e29-30. doi: 10.1097/TP.0b013e318208138c.
9
A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil.肝移植中急性体液排斥反应一例：血浆置换联合霉酚酸酯治疗成功
Transpl Int. 2005 Nov;18(11):1298-301. doi: 10.1111/j.1432-2277.2005.00200.x.
Zotero 插件